{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:50:15Z","timestamp":1773474615360,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["730713"],"award-info":[{"award-number":["730713"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10096-020-03926-4","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"1907-1914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of ultra-rapid susceptibility testing of ceftolozane-tazobactam by a flow cytometry assay directly from positive blood cultures"],"prefix":"10.1007","volume":"39","author":[{"given":"In\u00eas","family":"Martins-Oliveira","sequence":"first","affiliation":[]},{"given":"Blanca","family":"P\u00e9rez-Viso","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Quintas","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Silva-Dias","sequence":"additional","affiliation":[]},{"given":"Ros\u00e1rio","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Ac\u00e1cio G","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[]},{"given":"Cidalia","family":"Pina-Vaz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"12","key":"3926_CR1","first-page":"825","volume":"39","author":"M Sorbera","year":"2014","unstructured":"Sorbera M, Chung E, Ho CW, Marzella N (2014) Ceftolozane\/tazobactam: a new option in the treatment of complicated gram-negative infections. P & T : a peer-reviewed journal for formulary management 39(12):825\u2013832","journal-title":"P & T : a peer-reviewed journal for formulary management"},{"key":"3926_CR2","unstructured":"Organization WH (2016) World antibiotic awareness week 14-20 November WHO, WHO"},{"issue":"1","key":"3926_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","volume":"74","author":"GG Zhanel","year":"2014","unstructured":"Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagace-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA (2014) Ceftolozane\/tazobactam: a novel cephalosporin\/beta-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. Drugs 74(1):31\u201351. https:\/\/doi.org\/10.1007\/s40265-013-0168-2","journal-title":"Drugs"},{"key":"3926_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jgar.2019.10.009","volume":"21","author":"D Shortridge","year":"2019","unstructured":"Shortridge D, Pfaller MA, Streit JM, Flamm RK (2019) Antimicrobial activity of ceftolozane\/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme. Journal of global antimicrobial resistance 21:60\u201364. https:\/\/doi.org\/10.1016\/j.jgar.2019.10.009","journal-title":"Journal of global antimicrobial resistance"},{"issue":"3","key":"3926_CR5","doi-asserted-by":"publisher","first-page":"105887","DOI":"10.1016\/j.ijantimicag.2020.105887","volume":"55","author":"S Garcia-Fernandez","year":"2020","unstructured":"Garcia-Fernandez S, Garcia-Castillo M, Melo-Cristino J, Pinto MF, Goncalves E, Alves V, Vieira AR, Ramalheira E, Sancho L, Diogo J, Ferreira R, Silva D, Chaves C, Passaro L, Paixao L, Canton R (2020) In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: the STEP multicenter study. International journal of antimicrobial agents 55(3):105887. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105887","journal-title":"International journal of antimicrobial agents"},{"issue":"5","key":"3926_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijantimicag.2019.02.004","volume":"53","author":"S Garcia-Fernandez","year":"2019","unstructured":"Garcia-Fernandez S, Garcia-Castillo M, Bou G, Calvo J, Cercenado E, Delgado M, Pitart C, Mulet X, Tormo N, Mendoza DL, Diaz-Reganon J, Canton R (2019) Activity of ceftolozane\/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: the SUPERIOR multicentre study. International journal of antimicrobial agents 53(5):682\u2013688. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.02.004","journal-title":"International journal of antimicrobial agents"},{"key":"3926_CR7","doi-asserted-by":"publisher","unstructured":"Siddiqui S, Razzak J (2010) Early versus late pre-intensive care unit admission broad spectrum antibiotics for severe sepsis in adults. The Cochrane database of systematic reviews (10):Cd007081. https:\/\/doi.org\/10.1002\/14651858.CD007081.pub2","DOI":"10.1002\/14651858.CD007081.pub2"},{"issue":"9","key":"3926_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmi.2018.03.031","volume":"24","author":"G Dubourg","year":"2018","unstructured":"Dubourg G, Lamy B, Ruimy R (2018) Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clinical Microbiology and Infection 24(9):935\u2013943. https:\/\/doi.org\/10.1016\/j.cmi.2018.03.031","journal-title":"Clinical Microbiology and Infection"},{"issue":"7","key":"3926_CR9","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1128\/jcm.00313-13","volume":"51","author":"A van Belkum","year":"2013","unstructured":"van Belkum A, Dunne WM Jr (2013) Next-generation antimicrobial susceptibility testing. Journal of clinical microbiology 51(7):2018\u20132024. https:\/\/doi.org\/10.1128\/jcm.00313-13","journal-title":"Journal of clinical microbiology"},{"key":"3926_CR10","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.3389\/fmicb.2017.02455","volume":"8","author":"S Costa-de-Oliveira","year":"2017","unstructured":"Costa-de-Oliveira S, Teixeira-Santos R, Silva AP, Pinho E, Mergulhao P, Silva-Dias A, Marques N, Martins-Oliveira I, Rodrigues AG, Paiva JA, Canton R, Pina-Vaz C (2017) Potential impact of flow cytometry antimicrobial susceptibility testing on the clinical management of gram-negative bacteremia using the FASTinov((R)) kit. Frontiers in microbiology 8:2455. https:\/\/doi.org\/10.3389\/fmicb.2017.02455","journal-title":"Frontiers in microbiology"},{"issue":"10","key":"3926_CR11","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1021\/ja01202a053","volume":"69","author":"FT Gucker Jr","year":"1947","unstructured":"Gucker FT Jr, O'Konski CT et al (1947) A photoelectronic counter for colloidal particles. Journal of the American Chemical Society 69(10):2422\u20132431. https:\/\/doi.org\/10.1021\/ja01202a053","journal-title":"Journal of the American Chemical Society"},{"issue":"2","key":"3926_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/cmr.13.2.167-195.2000","volume":"13","author":"A Alvarez-Barrientos","year":"2000","unstructured":"Alvarez-Barrientos A, Arroyo J, Canton R, Nombela C, Sanchez-Perez M (2000) Applications of flow cytometry to clinical microbiology. Clinical microbiology reviews 13(2):167\u2013195. https:\/\/doi.org\/10.1128\/cmr.13.2.167-195.2000","journal-title":"Clinical microbiology reviews"},{"key":"3926_CR13","doi-asserted-by":"crossref","unstructured":"Cid\u00e1lia Pina-Vaz, Sofia Costa-de-Oliveira, Ana Silva Dias, Ana Pinto Silva, Rita Teixeira Santos (2017) Flow cytometry in microbiology: the reason and the need. In: Cossarizza JPRaA (ed) Single cell analysis \u2013 contemporary research and clinical applications. 1st edn edn. Springer Nature Singapore Pte Ltd, Singapore, pp 153-169","DOI":"10.1007\/978-981-10-4499-1_7"},{"issue":"Pt 6","key":"3926_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1099\/jmm.0.024075-0","volume":"60","author":"MJ Espinar","year":"2011","unstructured":"Espinar MJ, Rocha R, Ribeiro M, Goncalves Rodrigues A, Pina-Vaz C (2011) Extended-spectrum beta-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system. Journal of medical microbiology 60(Pt 6):756\u2013760. https:\/\/doi.org\/10.1099\/jmm.0.024075-0","journal-title":"Journal of medical microbiology"},{"key":"3926_CR15","doi-asserted-by":"publisher","unstructured":"Fonseca ESD, Silva-Dias A, Gomes R, Martins-Oliveira I, Ramos MH, Rodrigues AG, Canton R, Pina-Vaz C (2019) Evaluation of rapid colistin susceptibility directly from positive blood cultures using a flow cytometry assay. International journal of antimicrobial agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.016","DOI":"10.1016\/j.ijantimicag.2019.08.016"},{"key":"3926_CR16","unstructured":"Pina Vaz C, Rodrigues A, Faria Ramos IC, Costa De Oliveira AS, Pinto E Silva AT, Silva Dias A, Teixeira Dos Santos R (2016) Fluorescent method of detecting microorganisms resistant to a therapeutic agent United States Patent US 9,290,790 B2"},{"key":"3926_CR17","unstructured":"Pina Vaz C, Rodrigues A, Faria Ramos IC, Rocha Do Ros\u00e1rio R, Costa De Oliveira AS, Pinto E Silva AT (2017) Method of detecting the resistant microorganisms to a therapeutic agent. European Patent EP 2 714 922 B1"},{"key":"3926_CR18","doi-asserted-by":"publisher","unstructured":"Puttaswamy S, Doo Lee B, Sengupta S (2011) Novel electrical method for early detection of viable bacteria in blood cultures, vol 49. https:\/\/doi.org\/10.1128\/JCM.00369-11","DOI":"10.1128\/JCM.00369-11"},{"key":"3926_CR19","unstructured":"Testing ECoAS (2019) European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 9.0, valid from 2019-01-01 edn"},{"key":"3926_CR20","unstructured":"Institute CaLS (2019) M100 performance standards for antimicrobial susceptibility testing 29th edn"},{"key":"3926_CR21","unstructured":"Systems CLTaIVDT (2019) Susceptibility testing of infection agents and evaluation of performance of antimicrobial susceptibility test devices part 1: reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases vol ISO\/FDIS 20776-1:2019"},{"issue":"6","key":"3926_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10096-019-03498-y","volume":"38","author":"JM Lopez-Pintor","year":"2019","unstructured":"Lopez-Pintor JM, Navarro-San Francisco C, Sanchez-Lopez J, Garcia-Caballero A, Loza Fernandez de Bobadilla E, Morosini MI, Canton R (2019) Direct antimicrobial susceptibility testing from the blood culture pellet obtained for MALDI-TOF identification of Enterobacterales and Pseudomonas aeruginosa. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 38(6):1095\u20131104. https:\/\/doi.org\/10.1007\/s10096-019-03498-y","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"issue":"7","key":"3926_CR23","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1128\/jcm.00181-17","volume":"55","author":"M Marschal","year":"2017","unstructured":"Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S (2017) Evaluation of the Accelerate Pheno system for fast identification and antimicrobial susceptibility testing from positive blood cultures in bloodstream infections caused by gram-negative pathogens. Journal of clinical microbiology 55(7):2116\u20132126. https:\/\/doi.org\/10.1128\/jcm.00181-17","journal-title":"Journal of clinical microbiology"},{"key":"3926_CR24","doi-asserted-by":"crossref","unstructured":"Ovia\u00f1o M, G\u00f3mara M, Barba MJ, Revillo MJ, Barbeyto LP, Bou G (2017) Towards the early detection of \u03b2-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis. Journal of Antimicrobial Chemotherapy 72 (8):2259-2262. 10.1093\/jac\/dkx127 %J Journal of Antimicrobial Chemotherapy","DOI":"10.1093\/jac\/dkx127"},{"key":"3926_CR25","unstructured":"Systems CLTaIVDT (2007) Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices part 2: evaluation of performance of antimicrobial susceptibility test devices, vol ISO 20776-2:2007"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-03926-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T23:24:36Z","timestamp":1622589876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-03926-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03926-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Rafael Cant\u00f3n has participated in educational programs sponsored by MSD. FASTinov is a spin-off of Porto University founded by some of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethical committee of this center (Ref. 161-17).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}